Robbo,
Athersys covered by SCE on page 49 of 3/3/2011 report ( No 10 of listed competitors) and they did a small partnering deal with Pfizer in Dec 2009(pre MSB/CEPH).
This was on the back of Pfizer launching there own regenerative research unit in November 2008.
http://www.businesswire.com/news/home/20081114005161/en/Pfizer-Launches-Global-Regenerative-Medicine-Research-Unit
Competion is good Robbo( albeit only small IMO and Msb yrs ahead)...and it keeps MSB management focused.
By the way on 7/2/2011 Pfizer announced due to R & D cuts they were abandoning there regenerative medicine research in Cambridge.
http://pubs.acs.org/cen/news/89/i06/8906notw1.html.
Wouldnt know what this means but IMHO reading b/w the lines there is a lot more work to be done if Pfizer want to be a major player in the $bn dollar regenerative medicine industry.
In my view, I see their alliance with Athersys as a positive for the Stem Cell Industry.
Cheers.
from biotech...nor sure if it's news!!!, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |